On August 26, 2019 Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, reported that the company plans to present at the following conferences in September (Press release, Iovance Biotherapeutics, AUG 26, 2019, View Source [SID1234539017]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

RW Baird 2019 Global Healthcare Conference in New York, Sept. 4-5, 2019
Location: InterContinental New York Barclay
Date/Time: Wednesday, Sept. 4, at 3:45 p.m. EDT
Wells Fargo Securities 2019 Healthcare Conference in Boston, Sept. 4-5, 2019
Location: The Westin Copley Place
Date/Time: Thursday, Sept. 5, at 8:35 a.m. EDT
H.C. Wainwright 21st Annual Global Investment Conference in New York, Sept. 8-10, 2019
Location: Lotte New York Palace
Date/Time: Monday, Sept. 9, at 8:45 a.m. EDT
Live and archived webcasts of the presentations will be available by visiting the Investors section of the Iovance Biotherapeutics website at View Source